AI-generated summary
The authors report a pilot study of five men with mild-to-moderate androgenetic alopecia treated three times with a 1064-nm fractional picosecond laser. They report clinical improvement by expert assessment and higher patient satisfaction with hair density and thickness, with minimal adverse effects. The authors note that further research is needed.
- Participants
- 5
- Who or what was studied
- Five male participants with mild-to-moderate androgenetic alopecia
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract describes a pilot study with only five participants and calls for further research.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Androgenetic alopecia, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.